Stathi, A, et al.
Prevalence of emm-types 1 and 12 from invasive Streptococcus pyogenes disease in Greece – results of enhanced surveillance. Clinical Microbiology and Infection
2008; 14: 808–812.
O'Loughlin, RE, et al.
The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000–2004. Clinical Infectious Diseases
2007; 45: 853–862.
Rogers, S, et al.
Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections. Journal of Infectious Diseases
2007; 195: 1625–1633.
Wahl, RU, et al.
Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996–2002: results from a voluntary laboratory surveillance system. Clinical Microbiology and Infection
2007; 13: 1173–1178.
Tyrrell, GJ, et al.
Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002). Journal of Clinical Microbiology
2005; 43: 1678–1683.
Darenberg, J, et al.
Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clinical Infectious Diseases
2007; 45: 450–458.
Lamagni, TL, et al.
Increase in invasive group A streptococcal infections in England, Wales and Northern Ireland, 2008–2009. Eurosurveillance
2009; 14: pii 19110.
Luca-Harari, B, et al.
Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. Journal of Clinical Microbiology
2009; 47: 1155–1165.
Luca-Harari, B, et al.
Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. Journal of Clinical Microbiology
2008; 46: 79–86.
Passaro, DJ, et al.
Invasive group A streptococcal infections in the San Francisco Bay area, 1989–99. Epidemiology and Infection
2002; 129: 471–478.
Laupland, KB, et al.
Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics
2000; 105: E60.
Bingöl-Koloğlu, M, et al.
Necrotizing fasciitis in children: diagnostic and therapeutic aspects. Journal of Paediatric Surgery
2007; 42: 1892–1897.
Huang, YC, et al.
Characteristics of group A streptococcal bacteremia with comparison between children and adults. Journal of Microbiology Immunology and Infection
2001; 34: 195–200.
Zurawski, CA, et al.
Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment. Clinical Infectious Diseases
1998; 27: 150–157.
Davies, HD, et al.
Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. New England Journal of Medicine
1996; 335: 547–554.
Tyrrell, GJ, et al.
Varicella-associated invasive group A streptococcal disease in Alberta, Canada, 2000–2002. Clinical Infectious Diseases
2005; 40: 1055–1057.
Megged, O, et al.
Group A streptococcus bacteraemia: comparison of adults and children in a single medical centre. Clinical Microbiology and Infection
2006; 12: 156–162.
Breiman, RF, et al.
Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. Journal of the American Medical Association
1993; 269: 390–391.
Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial disk susceptibility tests; approved standard – tenth edition. CLSI Document M02-A10. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA, 2009.
Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing, Nineteenth informational supplement. CLSI document M100-S19. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA, 2009.
Seppala, H, et al.
Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. Journal of Antimicrobial Chemotherapy
1993; 32: 885–891.
Fujimura, T, et al.
Conversion of the CD4+ T cell profile from T(H2)-dominant type to T(H1)-dominant type after varicella-zoster virus infection in atopic dermatitis. Journal of Allergy and Clinical Immunology
1997; 100: 274–282.
Musser, JM, et al.
Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infection and Immunity
1995; 63: 994–1003.
Cleary, P, et al.
Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet
1992; 339: 518–521.
Schlievert, PM, Assimacopoulos, AP, Cleary, PP. Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis. Journal of Laboratory and Clinical Medicine
1996; 127: 13–22.